Dr. Shayna Nitin Mooney, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 413 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-493-4083 Fax: 360-486-6436 |
Arthur David Siek, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 413 Lilly Road Ne, Olympia, WA 98506 Phone: 360-491-9480 |
Dr. Edward Park, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 413 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-493-4083 |
Benjamin Capper, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7000 |
Dr. Usha R Emani, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3900 Capital Mall Dr Sw, Olympia, WA 98502 Phone: 360-704-4743 Fax: 360-704-4751 |
Susan V Links, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7089 |
Dr. Haomin Ye, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7000 Fax: 360-923-7089 |
Waleed Abraham, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 413 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-493-4083 Fax: 360-486-6436 |
Muhammad Ameen Ashraf, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7000 |
Michael G Mondress, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7000 |
News Archive
The U.S. Supreme Court is expected to rule shortly on whether generic drug companies must adequately warn doctors about new or revised risks to patients who have taken the drugs they make. (Pliva v Mensing No. 09-993, Actavis v Mensing No.08-3850 and Actavis v Demahy No. 09-1501) All three cases involve patients who took metoclopramide, the generic version of the brand-name drug Reglan.
Our brain extracts important information for face recognition principally from the eyes, and secondly from the mouth and nose, according to a new study from a researcher at the University of Barcelona.
Early adoption of tobacco control efforts in California lead to fewer people ever smoking, reduced the amount used by those who do smoke and helped smokers quit at a younger age - when their risk of developing lung cancer is lowest.
A team of scientists from Japan and the University of California, San Diego School of Medicine have created a new mouse model that confirms that mutations of a protein called beta-synuclein promote neurodegeneration. The discovery creates a potential new target for developing treatments of diseases like Parkinson's and Alzheimer's.
› Verified 5 days ago